BusinessFortis, Apollo, Max, Medanta Shares Rise After Cancer Drug Price Cap
Shares of Fortis Healthcare, Apollo Hospitals, Max, and Medanta rose after the government capped trade margins on non-scheduled anti-cancer drugs at 30%. This price cap could reduce drug costs by 20–70%, potentially saving patients ₹2,500 crore annually. Brokerages noted earnings impacts might be manageable but warned hospital profit margins could face pressure.
Mint Markets·